<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PRISM Trial research &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/prism-trial-research/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 23 Sep 2025 18:22:16 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>PRISM Trial research &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>UCLA to spearhead $16 Million National Research Initiative on AI in Breast Cancer Screening</title>
		<link>https://bioengineer.org/ucla-to-spearhead-16-million-national-research-initiative-on-ai-in-breast-cancer-screening/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 23 Sep 2025 18:22:12 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[AI breast cancer screening]]></category>
		<category><![CDATA[mammography accuracy]]></category>
		<category><![CDATA[multi-state clinical study]]></category>
		<category><![CDATA[patient-centered outcomes]]></category>
		<category><![CDATA[PRISM Trial research]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ucla-to-spearhead-16-million-national-research-initiative-on-ai-in-breast-cancer-screening/</guid>

					<description><![CDATA[UCLA and UC Davis are embarking on a groundbreaking research initiative that could reshape the landscape of breast cancer screening in the United States. Funded by a substantial $16 million grant from the Patient-Centered Outcomes Research Institute (PCORI), the PRISM Trial (Pragmatic Randomized Trial of Artificial Intelligence for Screening Mammography) is set to investigate the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">271523</post-id>	</item>
	</channel>
</rss>
